Asthma, Pneumonia, Respiratory Distress Syndrome
Conditions
Keywords
asthma, environmental intervention, respiratory distress, pediatric hospitalization, pneumonia, bronchiolitis
Brief summary
This study will investigate the efficacy of a novel air purification technology, Photo Electrochemical Oxidation (PECO), has on pediatric patients hospitalized for respiratory distress. The study will take place at Mercyhealth Hospital - Rockton Avenue where all 23 pediatric rooms will be outfitted with portable PECO air purifying units. The main outcomes are the length of stay and progression to ICU, which will be compared with historical controls.
Detailed description
The goal of this study is to assess whether using PECO to purify air in a hospital can improve health outcomes for pediatric patients with respiratory distress. The results of this study will be used in three primary ways: 1. As evidence to support an installation of PECO in hospital HVAC systems to improve the standard of care for patients with respiratory distress 2. Towards dissemination efforts through publication in a peer-reviewed journal and presentation at national and international conferences 3. For informing healthcare providers and stakeholders There are no plans to repeat this study with other hospital partners
Interventions
DEVICEPhoto Electrochemical Oxidation (PECO) for Air Purification
PECO air purifiers from Molekule will be placed in every patient room. Health metrics will be tracked for patients whose diagnosis is respiratory distress.
Sponsors
Mercy Health System
Molekule
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
1 Years to 17 Years
Healthy volunteers
No
Inclusion criteria
All pediatric patients who are admitted to the Mercyhealth Hospital - Rockton Avenue following the Start Date and have infectious or non-infectious respiratory distress as defined by the following ICD codes will be included in the study: * J00-J06: Acute upper respiratory infections * J09-J18: Influenza and pneumonia * J20-J22: Other acute lower respiratory infections * J30-J39: Other diseases of upper respiratory tract * J40-J47: Chronic lower respiratory diseases * J60-J70: Lung diseases due to external agents * J80-J84: Other respiratory diseases principally affecting the interstitium * J85-J86: Suppurative and necrotic conditions of the lower respiratory tract * J90-J94: Other diseases of the pleura * J95-J95: Intraoperative and postprocedural complications and disorders of respiratory system, not elsewhere classified
Exclusion criteria
* Any patient admitted to the NICU * Patients in the ER only * Any patient with non-respiratory conditions * Adults
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Length of stay | 5 months | Total length of hospital stay for patient |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Readmission rate | 1 months | Rate of readmission within 30 days of discharge |
Countries
United States
Outcome results
None listed